We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current NC6 market cap is 3.27M. The company's latest EPS is AUD -0.0067 and P/E is -2.99.
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 562k | 323k | 225k | 412k | 304k |
| Operating Income | -1.24M | -929k | -1.57M | -1.17M | -1.16M |
| Net Income | -1.24M | -931k | -1.57M | -1.35M | -1.16M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 1.02M | 3.38M | 1.91M | 633k | 242k |
| Total Liabilities | 237k | 508k | 182k | 181k | 466k |
| Total Equity | 785k | 2.87M | 1.73M | 452k | -224k |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -946k | -935k | -1.38M | -1.01M | -901k |
| Investing | -1,000 | -272k | -5k | N/A | 16k |
| Financing | 663k | 3.38M | -33k | -27k | 475k |
| Market Cap | 3.27M |
| Price to Earnings Ratio | -2.99 |
| Price to Sales Ratio | 11.11 |
| Price to Cash Ratio | 25 |
| Price to Book Ratio | -15.36 |
| Dividend Yield | - |
| Shares Outstanding | 172.01M |
| Average Volume (1 week) | 51.61k |
| Average Volume (1 Month) | 78.13k |
| 52 Week Change | -17.39% |
| 52 Week High | 0.032 |
| 52 Week Low | 0.016 |
| Spread (Intraday) | 0 (18.18%) |
| Company Name | Nanollose Limited |
| Address |
suite 5 perth, western australia 6009 |
| Website | https://www.nanollose.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
